5.0T MRI Explained: How It Compares with 3.0T and 1.5T, and When Field Strength Matters

Updated September 2026

One 5.0T MRI system, the uMR Jupiter, was approved in China in 2022 and cleared in the United States in 2024. This guide explains what the number changes, what the published evidence on 5.0T actually shows so far, and where it fits. If your question is about choosing between 1.5T and 3.0T, we have covered that in detail separately; this article focuses on 5.0T.

The short answer

• 1.5T and 3.0T are the established clinical field strengths.
• 5.0T is a new ultra-high-field class. The uMR Jupiter is approved in China (NMPA, 2022) and cleared in the US (FDA 510(k), 2024); its manufacturer also states it is CE-marked. A 2024 Chinese review lists it as installed at several large academic hospitals and research institutes. The clearest published differences from 3.0T are image measures in the brain and small intracranial vessels, from studies of 4 and 12 people; the body and heart studies are early and small.
• You choose field strength by the question, your implants and what is available, not by the biggest number. Higher field is not automatically better for every exam, and no MRI replaces endoscopy or biopsy where those are the reference tests.

What the "T" changes

Tesla (T) measures the strength of the scanner's main magnetic field. The signal MRI collects from your tissue rises roughly in proportion to field strength (AJNR, 2005). Radiologists spend that extra signal either on finer resolution or on a shorter scan.

In practice the gain is smaller than the theory. A systematic review of 150 studies comparing 1.5T and 3.0T brain imaging found that the "theoretical doubling of the signal-to-noise ratio was not confirmed, mostly being 25%", that artefacts were worse at 3.0T, and that objective evidence of better routine diagnosis was lacking (European Radiology, 2012).

Higher field also brings costs that scale with it. Energy deposited in the body rises with the square of the radio frequency, and susceptibility effects around metal and air increase (AJNR, 2005). The radio-frequency field also becomes less uniform inside the body at higher field (Radiology, 2023). Separately, when the FDA cleared the first 7T system in 2017, it limited it to "examinations of the head, arms and legs" (FDA, 2017).

1.5T and 3.0T: the routine clinical field strengths

• 1.5T is among the most widely used clinical field strengths, with mature, forgiving protocols for the abdomen, pelvis and spine, and a common choice for multi-region examinations.
• 3.0T is where radiologists use the extra signal on small structures: brain lesions, pituitary and inner-ear detail (AJNR, 2005), cartilage and small ligaments, and non-contrast angiography of intracranial vessels. The trade-offs are known and managed: more metal artefact unless the protocol is adapted (a phantom study: AJR, 2010), and the scanner reaches tissue-heating (SAR) limits sooner (AJNR, 2005).
• Implant labels. Under FDA labelling rules an "MR Conditional" device is safe only "within defined conditions including conditions for the static magnetic field", and "a medical device that is MR Conditional in a 1.5 T MR system may be unsafe in higher or lower field MR systems" (FDA guidance, 2023). The FDA's own example label reads "1.5T and 3T"; we have not seen a label that covers 5.0T.
• The MRI scans we book are 1.5T or 3.0T, and you choose the field strength when you book.

5.0T: what it is, and what the studies show

What it is. The uMR Jupiter (United Imaging) is a 5.0T scanner for the head, body and extremities, with an eight-channel parallel-transmit body coil, a 60 cm bore and 120 mT/m gradients (manufacturer specifications). China's regulator, the NMPA, approved it as an innovative device: it is listed in the NMPA's table of approved innovative devices (registration 国械注准20223061141), the approval was announced on 31 August 2022 (NMPA announcement, reprinted by CCFDIE), and the NMPA's 2022 registration report describes it for clinical MRI in patients over 20 kg (NMPA, 2023). The US FDA cleared it on 26 April 2024 (510(k) K233673) for imaging "of the head, body and extremities" in "patients > 20 kg/44 lbs" (FDA, 2024). We have checked the NMPA and FDA records directly. The manufacturer also states that the system is CE-marked (United Imaging, 2025); we have not seen the certificate.

What published studies show so far. All are early and small, and every one of them lists at least one author employed by or affiliated with the manufacturer, United Imaging. All five measure image properties; three are in healthy volunteers; four were scanned before the 2022 approval (two on described prototypes). None tested whether 5.0T changes a diagnosis or outcome. Read them as first technical evidence, not settled practice.

• Brain signal. In four healthy volunteers, average brain signal-to-noise at 5.0T was 1.6 times that at 3.0T, measured on a prototype 5T scanner with a custom 48-channel head coil, against a 32-channel coil at 3T. The same paper's head simulations showed less radio-frequency non-uniformity at 5.0T than at 7T. In one volunteer, at the same resolution, 5.0T susceptibility-weighted images showed more venous detail than 3.0T (visual comparison) (Quantitative Imaging in Medicine and Surgery, 2023).
• Small cerebral arteries. In 12 participants scanned at 3T, 5T and 7T within 48 hours, 5T time-of-flight angiography depicted distal branches and perforating arteries significantly better than 3T (total small-vessel length 5.1 m versus 1.9 m), with no evidence of a difference from 7T (Radiology, 2023). Of the studies we reviewed, this is the largest measured difference from 3.0T; it is one 12-person study of vessel visibility, not of diagnosis.
• Kidney. In 40 volunteers, T1-weighted images at 5T were better than at 3T with comparable artefacts; T2-weighted image quality was comparable, but with "a significantly higher level of artifacts" at 5T (Insights into Imaging, 2022).
• Upper abdomen diffusion. In nine volunteers, 5.0T diffusion imaging gave apparent-diffusion-coefficient values in agreement with 3.0T; subjective image quality was higher but not significantly so (Journal of Magnetic Resonance Imaging, 2022).
• Heart. In 18 patients with known myocardial fibrosis, 5T late-gadolinium-enhancement MRI was feasible, with higher signal-to-noise and contrast-to-noise at the same contrast dose, and no evidence of a difference in image-quality scores or in the amount of fibrosis measured compared with 3T (Radiology, 2024).

Where that leaves 5.0T today. A 2024 Chinese review lists it at several large academic hospitals and research institutes (Chinese review, 2024), and the published studies focus on the brain and small vessels. The manufacturer lists head, cardiac, cervical spine, joints, liver, kidney, pancreas and prostate among its applications (United Imaging). It is not the default for routine screening, and implant labels written for 1.5T and 3.0T do not carry over to it.

How to choose

1. Do you have an implant, clip, stimulator or pacemaker? The device's own MR label decides. Tell the clinic the exact model before booking. Labels commonly name 1.5T and 3.0T; if your device's label does not cover a field strength, the device has not been shown safe at that field strength, and the site's MR safety team decides (FDA guidance, 2023; RadiologyInfo).
2. Is the question broad? A multi-region examination is a 1.5T or 3.0T job. We have not found studies showing that a higher field strength changes screening MRI results.
3. Is the question narrow and small-structure? A known lesion in the brain, a small vessel, a pituitary or inner-ear question, fine cartilage: 3.0T is the standard. 5.0T may add detail for small intracranial vessels, where it is available and a radiologist recommends it.
4. Is it a specialist or research protocol? Advanced neuro, small-vessel and academic cardiac work is where 5.0T and 7T live, at some large hospitals and research institutes (as of a 2024 review).
5. Is it a gut or tissue question? No MRI, at any field strength, is on the recommended list of colorectal cancer screening tests, which are stool tests, colonoscopy, CT colonography and sigmoidoscopy (USPSTF, 2021). And "if imaging exams cannot clearly define the abnormality, a biopsy may be necessary" (RadiologyInfo).

Quick comparison

MRI uses a magnetic field and radio waves, not x-rays or ionising radiation (RadiologyInfo).

FAQ

Is 5.0T better than 3.0T? It depends on the question, and the evidence is early. In one study of 12 people, 5.0T angiography showed more small brain-vessel branches than 3.0T. In the heart and kidney studies, 5.0T gave more signal but no evidence of a difference in the measurements those studies compared (myocardial fibrosis quantification; diffusion values), and more artefact on kidney T2 images. We have not found studies showing that any of this changes a diagnosis or an outcome, or that a higher field strength changes screening MRI results.

Is 5.0T safe? Both the FDA clearance and China's NMPA approval are for patients over 20 kg (44 lb). The FDA found the system substantially equivalent to a 3.0T system from the same manufacturer. According to the submission, it conforms to IEC 60601-2-33, the MRI safety standard that sets tissue-heating limits, and the 20 kg limit comes from how its heating controls were modelled; the clearance was based on non-clinical testing, a volunteer study of nerve-stimulation limits and sample images, not clinical studies (FDA, 2024). Volunteers in one 5T study were told of possible short-lived effects of high-field MRI, such as mild nausea, vertigo, headache and tingling (Insights into Imaging, 2022). It does not cover your implant: your device's label decides, and labels written for 1.5T and 3.0T do not automatically cover 5.0T.

Can I get a 5.0T scan through SinoCareLink? No. 5.0T scans are not among the scans we book. They are available at some large hospitals and research institutes (as of a 2024 review), mostly for specialist or research protocols. If your doctor recommends a 5.0T scan, the scanning site can tell you whether it applies to your case.

How is 5.0T different from 7T? 7T is the higher field. When the FDA cleared the first 7T system in 2017, it limited it to examinations of the head, arms and legs (FDA, 2017); the uMR Jupiter was cleared in 2024 for the head, body and extremities, the same wording as the 3.0T system it was compared with (FDA, 2024). That wording describes permitted use, not image quality. In one 12-person study of the same people at 3T, 5T and 7T, small-vessel visibility at 5T showed no evidence of a difference from 7T; a study that size cannot show they are equivalent (Radiology, 2023).

This article is general information, not medical advice. Whether you need imaging, and at which field strength, is a decision for you and your doctor.